IX Acquisition Corp. Announces Fourth Extension of Deadline to Complete Initial Business Combination
11 juil. 2023 18h05 HE
|
IX Acquisition Corp.
NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) -- IX Acquisition Corp. (Nasdaq: IXAQ) (the “Company”) announced today that its board of directors (the “Board”) has decided to extend the date by which the...
ESH Acquisition Corp. Announces Closing of Initial Public Offering
28 juin 2023 14h46 HE
|
ESH ACQUISITION CORP.
Experienced leadership team seeking growing asset in the increasingly technology driven Entertainment, Sports, and Hospitality sectors NEW YORK, NEW YORK, June 28, 2023 (GLOBE...
Hairmax Featured on National TV Morning Show, Generates Over $275,000 in Revenue
28 juin 2023 08h59 HE
|
Hairmax
BOCA RATON, Fla., June 28, 2023 (GLOBE NEWSWIRE) -- On June 15th, Hairmax, the leader in transformative hair regrowth, was featured on one of the highest ranking syndicated, morning television shows...
Ferretti debuts at Piazza Affari on June 27, Iervolino as anchor investor
26 juin 2023 08h52 HE
|
Ferretti
MILAN, Italy, June 26, 2023 (GLOBE NEWSWIRE) -- Ferretti's luxury yachts are just one step away from Piazza Affari. The Group, currently listed on the Hong Kong Stock Exchange, announced the...
Hairmax Appoints Ryan F. Zackon as Chief Executive Officer
14 juin 2023 08h59 HE
|
Hairmax
BOCA RATON, Fla., June 14, 2023 (GLOBE NEWSWIRE) -- Hairmax, the pioneer and global leader in transformative hair regrowth, announced today that it has appointed Ryan F. Zackon as its Chief...
Skyward Specialty Announces Closing of Secondary Offering of its Common Stock
12 juin 2023 13h56 HE
|
Skyward Specialty Insurance Group, Inc.
HOUSTON, June 12, 2023 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.TM (NASDAQ: SKWD) ("Skyward Specialty" or the “Company"), a leader in the specialty property and casualty...
Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific Sessions
07 juin 2023 08h30 HE
|
Structure Therapeutics Inc.
SAN FRANCISCO and SHANGHAI, China, June 07, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small...
Skyward Specialty Announces Secondary Offering of Its Common Stock
05 juin 2023 16h59 HE
|
Skyward Specialty Insurance Group, Inc.
HOUSTON, June 05, 2023 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.TM (NASDAQ: SKWD) ("Skyward Specialty" or the "Company"), a leader in the specialty property and casualty...
Structure Therapeutics to Present at Jefferies Healthcare Conference
31 mai 2023 16h30 HE
|
Structure Therapeutics Inc.
SAN FRANCISCO and SHANGHAI, May 31, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule...
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity
25 mai 2023 16h30 HE
|
Structure Therapeutics Inc.
12-week Phase 2a and Phase 1b multiple ascending dose (MAD) topline results expected to be announced in latter half of fourth quarter 2023 Ethnobridging study initiated in Japanese individuals and...